Syntax Bio
Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine
$14.4MSeries A+
Role not disclosedLoading investors…
Activity from announced rounds
Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine
Measures molecular behaviour at scale to help pharma, food, and materials companies predict real-world product performance
Develops AI-driven drug discovery platform for first- and best-in-class therapeutics
Pitching Draper Associates? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room